Tech Company Financing Transactions
Acton Pharmaceuticals Funding Round
Acton Pharmaceuticals, operating out of Marlborough, secured $15 million from Sequoia Capital and private investors.
Transaction Overview
Company Name
Announced On
1/6/2010
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Sequoia Capital (Lead Investor) (Scott Carter)
Proceeds Purpose
We believe that AEROSPAN is an exciting opportunity, as it provides Acton with an excellent platform on which to build our organization.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
225 Cedar Hill St. 115
Marlborough, MA 01752
USA
Marlborough, MA 01752
USA
Phone
Website
Email Address
Overview
Acton is primarily focused on development and commercialization of innovative pharmaceutical products that treat allergic, pulmonary, and other respiratory related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Simon
Chief Financial Officer
Thomas Phair
Chief Medical Officer
Kenneth Newman
Chief Operating Officer
Daniel Kreisler
VP - Operations
Patrick Noland
Browse more venture capital transactions:
Prev: 1/6/2010: Clean Power Finance venture capital transaction
Next: 1/6/2010: Stylesight venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs